These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21724200)

  • 1. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder.
    Klotz S; Gebhard M; Sievers HH
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1270-1. PubMed ID: 21724200
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory pseudothrombus on a patent foramen ovale occluder device.
    MacKerrow S; Farb A; Sullivan R
    Tex Heart Inst J; 2011; 38(6):710-3. PubMed ID: 22199445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
    Korabathina R; Thaler DE; Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):498-502. PubMed ID: 21953702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder may be the result of Kounis hypersensitivity-associated syndrome.
    Kounis NG; Soufras GD; Mazarakis A
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):276; author reply 276-7. PubMed ID: 22710041
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-dimensional transesophageal echocardiography of a thrombus entrapped by a patent foramen ovale.
    Sattiraju S; Masri SC; Liao K; Missov E
    Ann Thorac Surg; 2012 Oct; 94(4):e101-2. PubMed ID: 23006715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment.
    Gori T; Schräder R; Genth-Zotz S
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):778-81. PubMed ID: 20091815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 8. Device-Associated Left Atrial Thrombosis Despite Oral Anticoagulation After Percutaneous Patent Foramen Ovale Closure.
    Tzimas G; Muller O; Kirsch M; Monney P
    Can J Cardiol; 2019 Nov; 35(11):1605.e5-1605.e6. PubMed ID: 31679631
    [No Abstract]   [Full Text] [Related]  

  • 9. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary embolism: a late complication of a correctly positioned occluder device for patent foramen ovale.
    Vigna C; Mazzoccoli GL; Santoro T; Di Eusanio G; Loperfido F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1057-8. PubMed ID: 18799970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Dimensional Transesophageal Echocardiography Reconstruction in Removal of a 7-cm Left Atrial Thrombus Attached to a Displaced Amplatzer Device.
    Koechlin L; Erb JM; Kohler C; Schaeffer T; Eckstein FS; Grapow MTR
    Circ Cardiovasc Imaging; 2018 Apr; 11(4):e007654. PubMed ID: 29650792
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-atrial mass-thrombus versus myxoma, post-amplatzer atrial septal defect closure device deployment.
    Gupta N; Abdelsalam M; Maini B; Mumtaz M; Mandak J
    J Am Coll Cardiol; 2012 Aug; 60(7):639. PubMed ID: 22878167
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
    Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
    Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
    [No Abstract]   [Full Text] [Related]  

  • 14. Late failure of Amplatzer device closure of a patent foramen ovale.
    Unai S; Bajwa G; Fischman DL; Entwistle JW; Hirose H
    J Card Surg; 2014 Nov; 29(6):801-2. PubMed ID: 25109750
    [No Abstract]   [Full Text] [Related]  

  • 15. Late thrombus formation on the Helex septal occluder after double-lung transplant.
    Zaidi AN; Cheatham JP; Galantowicz M; Astor T; Kovalchin JP
    J Heart Lung Transplant; 2010 Jul; 29(7):814-6. PubMed ID: 20382035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Atrial Thrombus Associated With Interatrial Septal Occluder 5 Years After Implantation.
    Misra S; Conte J; Resar J
    Circ Cardiovasc Interv; 2015 Oct; 8(10):e002856. PubMed ID: 26399266
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe allergic dermatitis after closure of foramen ovale with Amplatzer occluder.
    Belohlavek J; Belohlavkova S; Hlubocky J; Mrazek V; Linhart A; Podzimek S
    Ann Thorac Surg; 2013 Sep; 96(3):e57-9. PubMed ID: 23992730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombus formation 4 years after percutaneous transcatheter closure of an atrial septal defect.
    Furuta A; Nagashima M; Sugiyama H; Sakamoto T; Yamazaki K
    J Card Surg; 2017 Aug; 32(8):492-493. PubMed ID: 28743158
    [No Abstract]   [Full Text] [Related]  

  • 20. Echocardiographic diagnosis of a giant thrombus passing through a patent foramen ovale from right atrium to the left atrium.
    Bugra Z; Hunerel D; Tayyareci Y; Ruzgar O; Umman S; Tansel T; Meric M
    J Thromb Thrombolysis; 2008 Jun; 25(3):297-9. PubMed ID: 17589806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.